International Psoriasis Council

Advancing Knowledge. Enhancing Care.

Advancing Knowledge. Enhancing Care.

Telemedicine and Psoriasis

IMPROVING ACCESS TO EFFECTIVE TREATMENTS, TIMELY DIAGNOSIS, AND OPTIMAL CARE

Project Description

To date, telemedicine has been largely focused on “first contact visits.” Psoriasis presents unique challenges, including the need for long-term management. Telemedicine offers opportunities to develop novel approaches such as exploring artificial intelligence (AI) solutions and the personal management of psoriasis care. IPC convened a working group to establish a road map for how IPC can aid the development and implementation of telemedicine focused on psoriasis diagnosis and management. The telemedicine working group, chaired by Alexander Navarrini and co-chaired by Joel Gelfand, has completed a global consensus statement regarding telemedicine in psoriasis management, considering cultural and technological differences. Additional activities will include: defining best practices for using telemedicine in treating psoriasis, educating dermatologists on both the opportunities and limitations of telemedicine, and conducting research to understand better the barriers to care based on current reimbursement policies on a global level.

Project Leaders

Alexander

Navarini

,

MD, PhD

University Hospital of Basel

Basel

,

Switzerland

Joel

Gelfand

,

MD, MSCE

University of Pennsylvania

Philadelphia

,

Pennsylvania

,

United States

Working Group Members

  • April Armstrong, United States
  • Andrea Chiricozzi, Italy
  • Vahid Diamei, Switzerland
  • Mohamed El-Komy, Egypt
  • Christophe Hsu, Switzerland
  • Peter van de Kerkhof, Netherlands, IPC CMO
  • Christy Langan, USA, IPC CEO